Suppr超能文献

肢体局部晚期软组织肉瘤的多模式治疗

Multimodality treatment of locally advanced soft-tissue sarcomas of the extremities.

作者信息

Ravo Vincenzo, Marrone Immacolata, Morra Anna, Manzo Roberto, Murino Paola, Cammarota Fabrizio, Muto Paolo

机构信息

U.O.C. di Radioterapia Presidio Ospedaliero C. Ascalesi, Napoli, Italy.

Dipartimento Assistenziale di Radiologia e Radioterapia - Seconda Università degli Studi di Napoli, Italy.

出版信息

Rep Pract Oncol Radiother. 2010 Oct 6;15(5):119-24. doi: 10.1016/j.rpor.2010.08.006. eCollection 2010.

Abstract

BACKGROUND

Adjuvant radiotherapy (RTE) still has a fundamental role as a post-operative treatment of locally advanced soft tissues sarcomas of the extremities. Moreover the employment of combined modalities in locally advanced soft tissues sarcomas of the extremities allow to maximize the chance of local cure even in difficult presentation cases, and possibly improve survival, especially in high-risk disease patients. In patients with sarcomas of the extremities in which definitive surgery has not been radical (with positive or "close" margins) radiotherapy can improve the results in terms of Disease Free Survival (DFS) and, together with chemotherapy, of Overall Survival (OS). We recommend radiotherapy in case of deep tumor location, inadequate surgical margins and grade 3 tumour; for positive or "marginal (or close)" excision (that means inadequate surgery) or in selected patients with a bad prognosis, we believe that a multidisciplinary approach can be preferable.

INTRODUCTION

Adjuvant radiotherapy (RTE) still has a fundamental role as a post-operative treatment. In patients with sarcomas of the extremities in whom definitive surgery has been or not radical (positive or "close" margins), radiotherapy with chemotherapy can improve the results in terms of Disease Free Survival (DFS) and Overall Survival (OS), while RTE alone seems to improve local control.

MATERIALS AND METHODS

From 1/2000 to 12/2005 we treated 34 patients affected by locally advanced sarcomas of the upper or lower extremities with radiotherapy (doses ranging from 54 to 66 Gy) and chemotherapy in 18/34 with an adjuvant scheme that consisted in Epirubicine (120 mg/m(2)) plus Ifosfamide (7000-9000 mg/m(2)).

RESULTS

Disease Free Survival (DFS) and the Overall Survival (OS) rates were 76% and 82%, respectively. Eighteen patients developed one or more long-term side effects. Most of these complications were mild: all patients experienced only erithema, edema, local sclerosis or moderate pain.

CONCLUSION

Radiotherapy has an important role as a post-operative treatment also when surgery was non-radical. It improves local control more in patients with high-grade sarcomas of the extremity with positive or close margins. It is still difficult to assess the role of adjuvant chemotherapy.

摘要

背景

辅助放疗(RTE)作为肢体局部晚期软组织肉瘤的术后治疗仍具有重要作用。此外,在肢体局部晚期软组织肉瘤中采用联合治疗方式,即使在病情复杂的情况下,也能最大程度地提高局部治愈的机会,并有可能提高生存率,尤其是在高危疾病患者中。对于肢体肉瘤患者,如果根治性手术未达到根治效果(切缘阳性或“接近”切缘),放疗可在无病生存期(DFS)方面改善治疗效果,并且与化疗一起可改善总生存期(OS)。对于肿瘤位置深、手术切缘不充分和3级肿瘤的情况,我们建议进行放疗;对于切缘阳性或“边缘(或接近)”切除(即手术不充分)的情况或在某些预后不良的患者中,我们认为多学科方法可能更可取。

引言

辅助放疗(RTE)作为术后治疗仍具有重要作用。对于肢体肉瘤患者,无论根治性手术是否达到根治效果(切缘阳性或“接近”切缘),放疗联合化疗可在无病生存期(DFS)和总生存期(OS)方面改善治疗效果,而单纯辅助放疗似乎可改善局部控制。

材料与方法

从2000年1月至2005年12月,我们对34例上肢或下肢局部晚期肉瘤患者进行了放疗(剂量范围为54至66 Gy),其中18例联合化疗,辅助化疗方案为表柔比星(120 mg/m²)加异环磷酰胺(7000 - 9000 mg/m²)。

结果

无病生存期(DFS)和总生存期(OS)率分别为76%和82%。18例患者出现一种或多种长期副作用。这些并发症大多较轻:所有患者仅出现红斑、水肿、局部硬化或中度疼痛。

结论

即使手术不彻底,放疗作为术后治疗也具有重要作用。对于切缘阳性或接近切缘的肢体高级别肉瘤患者,放疗能更好地改善局部控制。辅助化疗的作用仍难以评估。

相似文献

1
Multimodality treatment of locally advanced soft-tissue sarcomas of the extremities.
Rep Pract Oncol Radiother. 2010 Oct 6;15(5):119-24. doi: 10.1016/j.rpor.2010.08.006. eCollection 2010.
4
Treatment and local control of primary extremity soft tissue sarcomas.
J Surg Oncol. 1999 Jul;71(3):155-61. doi: 10.1002/(sici)1096-9098(199907)71:3<155::aid-jso4>3.0.co;2-7.
8
Influence of surgical margins on outcome in patients with preoperatively irradiated extremity soft tissue sarcomas.
Cancer. 1994 Mar 15;73(6):1652-9. doi: 10.1002/1097-0142(19940315)73:6<1652::aid-cncr2820730617>3.0.co;2-x.

引用本文的文献

1
PROMIS scores of patients undergoing neoadjuvant and adjuvant radiation therapy for surgically excised soft tissue sarcoma.
Clin Transl Radiat Oncol. 2021 Aug 29;31:42-49. doi: 10.1016/j.ctro.2021.08.008. eCollection 2021 Nov.
2
Looking for answers: the current status of neoadjuvant treatment in localized soft tissue sarcomas.
Cancer Chemother Pharmacol. 2016 Nov;78(5):895-919. doi: 10.1007/s00280-016-3055-1. Epub 2016 May 20.

本文引用的文献

1
Standards and novel therapeutic options in the treatment of patients with soft tissue sarcoma.
Rev Recent Clin Trials. 2007 Sep;2(3):206-11. doi: 10.2174/157488707781662706.
3
Sarcoma.
Mayo Clin Proc. 2007 Nov;82(11):1409-32. doi: 10.4065/82.11.1409.
4
A review of soft tissue sarcoma.
Niger J Med. 2007 Apr-Jun;16(2):94-101. doi: 10.4314/njm.v16i2.37289.
5
Local management of adult soft tissue sarcomas.
Semin Oncol. 2007 Jun;34(3):256-69. doi: 10.1053/j.seminoncol.2007.03.008.
6
Soft tissue sarcoma: preoperative and postoperative imaging for staging.
Surg Oncol Clin N Am. 2007 Apr;16(2):389-402. doi: 10.1016/j.soc.2007.03.006.
7
Opportunities for improving the therapeutic ratio for patients with sarcoma.
Lancet Oncol. 2007 Jun;8(6):513-24. doi: 10.1016/S1470-2045(07)70169-9.
8
[Neoadjuvant chemotherapy in sarcoma].
Bull Cancer. 2006 Nov;93(11):1093-8.
9
Grading of soft tissue sarcomas: review and update.
Arch Pathol Lab Med. 2006 Oct;130(10):1448-53. doi: 10.5858/2006-130-1448-GOSTSR.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验